The ProBio trial: molecular biomarkers for advancing personalized treatment decision in patients with metastatic castration-resistant prostate cancer.

Alessio CrippaBram De LaereAndrea DiscacciatiBerit LarssonJason T ConnorErin E GabrielCamilla ThellenbergElin JänesGunilla EnbladAnders UllenMarie Hjälm-ErikssonJan OldenburgPiet OstJohan LindbergMartin EklundHenrik Grönberg

Published in: Trials (2020)

ClinicalTrials.gov Identifier NCT03903835. Date of registration: April 4, 2019. Status: Recruiting.

Keyphrases

study protocol
phase iii
phase ii
decision making
randomized controlled trial